📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. (2021)

First Author: Gondim MVP

Attributed to: Design of HIV vaccines that stimulate T cell and NK cell immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abd8179

PubMed Identifier: 33441429

Publication URI: http://europepmc.org/abstract/MED/33441429

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 576

ISSN: 1946-6234